• 1. Embedding cyclic nitrone in mesoporous silica particles for EPR spin trapping of superoxide and other radicals?
  Eric Besson,Stéphane Gastaldi,Emily Bloch,Selma Aslan,Hakim Karoui,Olivier Ouari,Micael Hardy Analyst, 2019,144, 4194-4203
• 2. Establishment and implications of a characterization method for magnetic nanoparticle using cell tracking velocimetry and magnetic susceptibility modified solutions
  Huading Zhang,Lee R. Moore,Maciej Zborowski,P. Stephen Williams,Shlomo Margel,Jeffrey J. Chalmers Analyst, 2005,130, 514-527
• 3. Empowering microfluidics by micro-3D printing and solution-based mineral coating?
  Hongxia Li,Aikifa Raza,Qiaoyu Ge,Jin-You Lu,TieJun Zhang Soft Matter, 2020,16, 6841-6849
• 4. Excimer emission and magnetoluminescence of radical-based zinc(ii) complexes doped in host crystals?
  Shojiro Kimura,Tetsuro Kusamoto Chem. Commun., 2020,56, 11195-11198
• 5. Evidence of CO2 molecule acting as an electron acceptor on a nanoporous metal–organic-framework MIL-53 or Cr3+(OH)(O2C–C6H4–CO2)?
  Alexandre Vimont,Arnaud Travert,Philippe Bazin,Jean-Claude Lavalley,Marco Daturi,Christian Serre,Gérard Férey,Sandrine Bourrelly,Philip L. Llewellyn Chem. Commun., 2007, 3291-3293

Introduction to 5-Acetyl-3-methyl-1H-indole-2-carboxylic acid (CAS No. 91569-51-6)

5-Acetyl-3-methyl-1H-indole-2-carboxylic acid, identified by the Chemical Abstracts Service registry number 91569-51-6, is a significant compound in the realm of organic chemistry and pharmaceutical research. This heterocyclic compound belongs to the indole family, which is renowned for its diverse biological activities and applications in medicinal chemistry. The structural motif of indole, combined with acetyl and methyl substituents, endows this molecule with unique chemical properties that make it a valuable scaffold for drug discovery and synthetic chemistry.

The molecular structure of 5-Acetyl-3-methyl-1H-indole-2-carboxylic acid consists of a benzene ring fused to a pyrrole ring, with an acetyl group at the 5-position and a methyl group at the 3-position. This configuration not only contributes to its distinct spectral characteristics but also influences its reactivity and interaction with biological targets. The presence of the carboxylic acid functional group at the 2-position further enhances its potential as a precursor in the synthesis of more complex molecules, including pharmaceutical intermediates and bioactive agents.

In recent years, there has been growing interest in indole derivatives due to their broad spectrum of biological activities. 5-Acetyl-3-methyl-1H-indole-2-carboxylic acid has emerged as a key intermediate in the synthesis of various pharmacologically relevant compounds. Researchers have explored its utility in developing molecules with potential applications in treating neurological disorders, infectious diseases, and cancer. The acetyl and methyl groups in its structure provide handles for further functionalization, allowing chemists to tailor the properties of derived compounds to specific biological needs.

One of the most compelling aspects of 5-Acetyl-3-methyl-1H-indole-2-carboxylic acid is its role in the synthesis of indole-based drugs that modulate enzyme activity and receptor binding. For instance, derivatives of this compound have been investigated for their ability to inhibit enzymes involved in inflammation and oxidative stress, which are key mechanisms in many pathological conditions. The acetyl group, in particular, has been shown to enhance binding affinity to certain biological targets, making it a valuable feature for drug design.

Recent advancements in computational chemistry have also highlighted the importance of 5-Acetyl-3-methyl-1H-indole-2-carboxylic acid as a scaffold for virtual screening and drug design. Molecular docking studies have demonstrated its potential interaction with various protein targets, including those implicated in metabolic disorders and neurodegenerative diseases. These studies not only provide insights into the structural requirements for binding but also guide the development of novel therapeutic agents.

The synthetic pathways for 5-Acetyl-3-methyl-1H-indole-2-carboxylic acid have been optimized to ensure high yield and purity, making it accessible for industrial-scale production. Traditional methods involve condensation reactions between appropriate precursors, followed by functional group transformations to introduce the acetyl and methyl groups. However, modern synthetic approaches have leveraged catalytic methods and green chemistry principles to improve efficiency and sustainability.

The pharmacological profile of 5-Acetyl-3-methyl-1H-indole-2-carboxylic acid has been further explored through preclinical studies. These investigations have revealed promising results in models of inflammation, pain, and neuroprotection. The compound’s ability to cross the blood-brain barrier has also been noted, suggesting potential applications in central nervous system disorders. While further research is needed to fully elucidate its therapeutic potential, these preliminary findings underscore its significance as a lead compound.

In conclusion, 5-Acetyl-3-methyl-1H-indole-2-carboxylic acid (CAS No. 91569-51-6) represents a fascinating example of how structural modifications can influence biological activity. Its unique combination of substituents makes it a versatile building block for pharmaceutical development. As research continues to uncover new applications and synthetic strategies, this compound is poised to play an increasingly important role in the discovery and development of novel therapeutics.

• 10590-73-5(3-Methyl-1H-indole-2-carboxylic acid)
• 28737-34-0(3-Formyl-1H-indole-2-carboxylic acid)
• 92287-88-2(3-Ethyl-1H-indole-2-carboxylic acid)
• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)